PrognomiQ Inc Company Profile, Contacts & Intelligence

Biotechnology Research1900 Alameda De Las Pulgas59 employeesSEERFounded 2020
3 contacts with email or phone data3 with email data1 with phone data
Employees
59
Company source estimate
Reachable Contacts
3
Visible contacts with email or phone data
Contacts With Email
3
3 of 4 visible contacts

PrognomiQ Inc Overview

PrognomiQ aims to generate proteomic information with high accuracy, scale and speed. This proteomic data will be complemented with genomic, metabolomic and other health information to deliver first-in-class test products that enable early disease detection and treatment. Powerful, Untapped Disease Insights Built on a Proteomics Foundation: Until now, there have been major technical and economic barriers to broad-scale proteomics analyses, leaving this rich resource of molecular information largely untapped for clinical purposes. These barriers have now been largely addressed through next generation tools that can elucidate complex proteomics at scale. Complementary Molecular Information: Genomic data has made clear contributions to researchers’ abilities to understand and more precisely treat disease, but it is has shown limited impact on early-stage disease detection. Proteomics provides direct information on the biological state of a cell, including disease at its earliest state, but proteomics data has been technically difficult to generate – until now. By complementing the new sources of proteomics data with genomics and other data, such as metabolomics, we now have the tools to generate powerful multi-omics data that will be the key to unlock the detection and treatment of disease at its earliest stages, when these diseases are most likely to be cured. Unlocking Disease Detection and Treatment with Multi-omics Data: We designed our proprietary multi-omics platform around the most robust approaches to generating proteomic, genomic and metabolomics data at scale, including the use of the Proteograph technology platform from the life science tools company Seer (NASDAQ: SEER) whom PrognomiQ spun out of in 2020.

Headquarters
1900 Alameda De Las Pulgas
Industry
Biotechnology Research
Founded
2020
Stock Symbol
SEER
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

PrognomiQ Inc Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

3 contacts with contact data
3 with email data and 1 with phone data in the visible sample.

PrognomiQ Inc People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

PrognomiQ Inc Workforce Composition

Seniority breakdown across 4 visible profiles.

Individual contributor
2
Executive
1
Director
1

Compare Similar Companies to PrognomiQ Inc

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Natera Biotechnology Research 4.96K View company
10x Genomics Biotechnology Research 2.24K View company
Beam Therapeutics Biotechnology Research 557 View company
Freenome Biotechnology Research 412 View company
SomaScan Biotechnology Research 234 View company
Quantum-Si Biotechnology Research 188 View company
Alamar Biosciences, Inc. Biotechnology Research 164 View company
Seer Biotechnology Research 154 View company
Nautilus Biotechnology Biotechnology Research 141 View company
Inoviv Biotechnology 27 View company